Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $2.3 billion.

  • Conmed's Liabilities and Shareholders Equity rose 84.56% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.3 billion, marking a year-over-year increase of 62.4%. This contributed to the annual value of $2.3 billion for FY2025, which is 84.56% up from last year.
  • Per Conmed's latest filing, its Liabilities and Shareholders Equity stood at $2.3 billion for Q4 2025, which was up 84.56% from $2.3 billion recorded in Q3 2025.
  • In the past 5 years, Conmed's Liabilities and Shareholders Equity registered a high of $2.3 billion during Q2 2025, and its lowest value of $1.7 billion during Q1 2021.
  • For the 5-year period, Conmed's Liabilities and Shareholders Equity averaged around $2.2 billion, with its median value being $2.3 billion (2023).
  • In the last 5 years, Conmed's Liabilities and Shareholders Equity surged by 3066.84% in 2022 and then tumbled by 159.75% in 2024.
  • Quarter analysis of 5 years shows Conmed's Liabilities and Shareholders Equity stood at $1.8 billion in 2021, then skyrocketed by 30.1% to $2.3 billion in 2022, then rose by 0.11% to $2.3 billion in 2023, then rose by 0.27% to $2.3 billion in 2024, then grew by 0.85% to $2.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $2.3 billion in Q4 2025, compared to $2.3 billion in Q3 2025 and $2.3 billion in Q2 2025.